The research was part of an international consortium, The Pan Prostate Cancer Group, which analyzed genetic data from thousands of prostate cancer samples across nine countries. The team's collaboration with Cancer Research UK aims to develop a genetic test that, combined with conventional staging and grading, can provide a more precise prognosis for each patient. The researchers used AI to study changes in the DNA of prostate cancer samples from 159 patients, identifying two distinct cancer groups. This finding was validated in other independent datasets from Canada and Australia.
Key takeaways:
- Artificial Intelligence has helped scientists discover a new form of aggressive prostate cancer, potentially revolutionising future diagnosis and treatment.
- The study revealed that prostate cancer includes two different subtypes, or 'evotypes', a discovery made by an international team using AI on DNA data.
- The research could lead to tailored treatments for each patient based on a genetic test delivered using AI, potentially saving thousands of lives.
- The researchers used AI to study changes in the DNA of prostate cancer samples, identifying two distinct cancer groups among the patients, a finding validated in independent datasets from Canada and Australia.